DM2: Murine and cell Culture Models of CCUG RNA toxicity

DM2:CCUG RNA 毒性的小鼠和细胞培养模型

基本信息

  • 批准号:
    7227470
  • 负责人:
  • 金额:
    $ 43.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-15 至 2008-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Myotonic dystrophy (DM), the most common form of muscular dystrophy in adults, can be caused by a mutation on chromosome 19 (DM1) or 3 (DM2/PROMM). DM1 is caused by a CTG expansion in the 3' untranslated region of the dystrophia myotonica-protein kinase gene (DMPK) and the promoter region of the homeodomain gene SIX5. Although the DM1 mutation was isolated in 1992, for many years it has been difficult to understand how this mutation, which does not alter the protein-coding portion of a gene, causes this dominantly-inherited multisystemic disorder. Suggested mechanisms have included: DMPK haploinsufficiency; reduced expression of regional genes including the homeodomain gene SIX5; and pathogenic effects of the CUG expansion in RNA. Mouse models have suggested that each of these mechanisms contributes to DM1 pathogenesis and that DM1 may be a regional gene disorder. To clarify the pathogenic mechanism of DM, we have studied a second form of myotonic dystrophy that causes a strikingly similar constellation of clinical features in humans including myotonia, myopathy, iridescent cataracts, cardiac arrhythmias, and the specific set of serological changes characteristic of DM. We mapped the DM2 locus to chromosome 3q21 (Nature Genetics 19:196-198, 1998) and recently reported that DM2 is caused by a repeat expansion in intron 1 of the zinc finger protein nine (ZNF9) gene (Science, 293:864-867). Clinical and molecular parallels between DM1 and DM2 indicate that CUG and CCUG expansions expressed at the RNA but not the protein level can themselves be pathogenic and cause the multisystemic features common to both diseases. We propose generating transgenic mice and cell culture models to test the effects of CCUG repeat-containing transcripts and to better understand the molecular mechanisms involved in the disease process. Our specific aims are: (1) To generate a reversible murine model to test the pathogenicity and characterize the downstream effects of transcripts containing the CCUG expansion expressed in skeletal muscle. (2) To generate and characterize a BAC transgenic mouse model that replicates the multisystemic features of myotonic dystrophy type 2. (3) To develop a cell culture model to evaluate the molecular effects of CCUG length on the formation of RNA foci, cellular differentiation and downstream molecular changes in alternative splicing.
描述(由申请人提供):强直性肌营养不良(DM)是成人肌营养不良的最常见形式,可由19号染色体(DM 1)或3号染色体(DM 2/PROMM)上的突变引起。DM 1由肌强直性肌营养不良蛋白激酶基因(DMPK)的3'非翻译区和同源结构域基因SIX 5的启动子区中的CTG扩增引起。虽然DM 1突变在1992年被分离出来,但多年来一直难以理解这种不改变基因蛋白质编码部分的突变是如何导致这种显性遗传的多系统疾病的。提出的机制包括:DMPK单倍不足;包括同源结构域基因SIX 5在内的区域基因表达减少;以及RNA中CUG扩增的致病作用。小鼠模型表明,这些机制中的每一个都有助于DM 1的发病机制,DM 1可能是一种区域性基因疾病。为了阐明DM的致病机制,我们研究了第二种形式的强直性肌营养不良,其在人类中引起惊人相似的一系列临床特征,包括肌强直、肌病、虹彩性白内障、心律失常和DM特有的一组血清学变化。我们将DM 2基因座定位于染色体3q 21(Nature Genetics 19:196-198,1998),并且最近报道DM 2是由锌指蛋白9(ZNF 9)基因的内含子1中的重复扩增引起的(Science,293:864-867)。DM 1和DM 2之间的临床和分子相似性表明,在RNA而不是蛋白质水平表达的CUG和CCUG扩增本身可能是致病的,并导致两种疾病共同的多系统特征。我们建议产生转基因小鼠和细胞培养模型,以测试CCUG重复包含转录的影响,并更好地了解参与疾病过程的分子机制。我们的具体目标是:(1)建立可逆的小鼠模型,以测试致病性并表征在骨骼肌中表达的含有CCUG扩增的转录物的下游效应。(2)建立并表征复制强直性肌营养不良2型多系统特征的BAC转基因小鼠模型。(3)建立细胞培养模型,以评估CCUG长度对RNA灶形成、细胞分化和选择性剪接下游分子变化的分子效应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laura P.W Ranum其他文献

Laura P.W Ranum的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laura P.W Ranum', 18)}}的其他基金

Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model.
新型 C9orf72 BAC 小鼠模型中 ALS/FTD 的分子表征。
  • 批准号:
    9751987
  • 财政年份:
    2016
  • 资助金额:
    $ 43.19万
  • 项目类别:
Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model.
新型 C9orf72 BAC 小鼠模型中 ALS/FTD 的分子表征。
  • 批准号:
    9197026
  • 财政年份:
    2016
  • 资助金额:
    $ 43.19万
  • 项目类别:
Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model.
新型 C9orf72 BAC 小鼠模型中 ALS/FTD 的分子表征。
  • 批准号:
    9335570
  • 财政年份:
    2016
  • 资助金额:
    $ 43.19万
  • 项目类别:
Molecular effects of metformin, PKR and TBI on C9orf72 ALS/FTD
二甲双胍、PKR 和 TBI 对 C9orf72 ALS/FTD 的分子效应
  • 批准号:
    10586260
  • 财政年份:
    2016
  • 资助金额:
    $ 43.19万
  • 项目类别:
7th International Conference on Unstable Microsatellites in Human Disease
第七届人类疾病不稳定微卫星国际会议
  • 批准号:
    8323030
  • 财政年份:
    2012
  • 资助金额:
    $ 43.19万
  • 项目类别:
2011 CAG Triplet Repeat Disorders GRC/GRS
2011 CAG 三联体重复疾病 GRC/GRS
  • 批准号:
    8125467
  • 财政年份:
    2011
  • 资助金额:
    $ 43.19万
  • 项目类别:
Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects
强直性肌营养不良:分子病理生理学和中枢神经系统影响
  • 批准号:
    8303500
  • 财政年份:
    2008
  • 资助金额:
    $ 43.19万
  • 项目类别:
Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects
强直性肌营养不良:分子病理生理学和中枢神经系统影响
  • 批准号:
    8609099
  • 财政年份:
    2008
  • 资助金额:
    $ 43.19万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    8739681
  • 财政年份:
    2008
  • 资助金额:
    $ 43.19万
  • 项目类别:
REPEAT-ASSOCIATED NON-ATG TRANSLATION IN DM1 AND DM2
DM1 和 DM2 中重复相关的非 ATG 翻译
  • 批准号:
    8739677
  • 财政年份:
    2008
  • 资助金额:
    $ 43.19万
  • 项目类别:

相似海外基金

Impact of alternative polyadenylation of 3'-untranslated regions in the PI3K/AKT cascade on microRNA
PI3K/AKT 级联中 3-非翻译区的替代多聚腺苷酸化对 microRNA 的影响
  • 批准号:
    573541-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 43.19万
  • 项目类别:
    University Undergraduate Student Research Awards
How do untranslated regions of cannabinoid receptor type 1 mRNA determine receptor subcellular localisation and function?
1 型大麻素受体 mRNA 的非翻译区如何决定受体亚细胞定位和功能?
  • 批准号:
    2744317
  • 财政年份:
    2022
  • 资助金额:
    $ 43.19万
  • 项目类别:
    Studentship
MICA:Synthetic untranslated regions for direct delivery of therapeutic mRNAs
MICA:用于直接递送治疗性 mRNA 的合成非翻译区
  • 批准号:
    MR/V010948/1
  • 财政年份:
    2021
  • 资助金额:
    $ 43.19万
  • 项目类别:
    Research Grant
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10019570
  • 财政年份:
    2019
  • 资助金额:
    $ 43.19万
  • 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10223370
  • 财政年份:
    2019
  • 资助金额:
    $ 43.19万
  • 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10455108
  • 财政年份:
    2019
  • 资助金额:
    $ 43.19万
  • 项目类别:
Synergistic microRNA-binding sites, and 3' untranslated regions: a dialogue of silence
协同的 microRNA 结合位点和 3 非翻译区:沉默的对话
  • 批准号:
    255762
  • 财政年份:
    2012
  • 资助金额:
    $ 43.19万
  • 项目类别:
    Operating Grants
Analysis of long untranslated regions in Nipah virus genome
尼帕病毒基因组长非翻译区分析
  • 批准号:
    20790351
  • 财政年份:
    2008
  • 资助金额:
    $ 43.19万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Search for mRNA elements involved in the compatibility between 5' untranslated regions and coding regions in chloroplast translation
寻找参与叶绿体翻译中 5 非翻译区和编码区之间兼容性的 mRNA 元件
  • 批准号:
    19370021
  • 财政年份:
    2007
  • 资助金额:
    $ 43.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Post-transcriptional Regulation of PPAR-g Expression by 5'-Untranslated Regions
5-非翻译区对 PPAR-g 表达的转录后调控
  • 批准号:
    7131841
  • 财政年份:
    2006
  • 资助金额:
    $ 43.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了